ACAD (ACADIA PHARMACEUTICALS INC) BUY

11. März 2021

• ACAD LONG SET UP, ACAD Gapped down over 25% to a New 52 week low.
  Price should bounce and fill in the Gap in the market
  ACAD also filled its previous Buy gap from Sep 4th 2019
  

Title: Buy ACAD (ACADIA Pharmaceuticals)
Asset: Stock
Platform: Robinhood/WeBull/Etrade/ 401k account
Symbol: ACAD
Type: Buy Market Execution / Buy Limit
Time Frame: 1D
Entry Price 1: $26.50 ACTIVE
Entry Price 2: $22.50(PENDING)
Stop Loss: $19.50 (70 Pips)
Take Profit 1: $33.00 (70 pips)
Take Profit 2: $38.00 (140 pips)
Take Profit 3: $44.00 (200 pips)
Take Profit 4: $54.00 (300pips)
Status: 🏃🏽‍♂️Active🏃🏽‍♂️

Sector: Health Technology
Industry: Biotechnology
ACADIA Pharmaceuticals operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R Brann on July 16, 1993 and is headquartered in San Diego CA